Replies to post #12236 on IntelGenx Technologies Corp (IGXT)

[jevansac]

For products covered by a user fee program, if the product sponsor submitted the application and paid any required fees before the lapse, FDA can use its limited carryover user fee funding to continue reviewing the application.

This tweet?